Research Progress of Targeted Therapy for Anaplastic Lymphoma Kinase and Other Rare Driver Genes in Advanced Non-small Cell Lung Cancer
Targeted therapy was one of the major treatments in advanced non-small cell lung cancer (NSCLC) with positive driver genes. This area of research progresses day by day, with novel target discoveries, novel drug development, and use of novel combination treatments. Researchers have also undergone dee...
Main Authors: | Quan ZHANG, Shucai ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2017-01-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.10 |
Similar Items
-
Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase in Non-small Cell Lung Cancer
by: Li MA, et al.
Published: (2014-12-01) -
Current Status for Anaplastic Lymphoma Kinase in Non-small Cell Lung Cancer
by: Peng SONG, et al.
Published: (2018-09-01) -
The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
by: Brandon Golding, et al.
Published: (2018-02-01) -
Treatment of Patients with ALK-positive Non-small Cell Lung Cancer
and Brain Metastases
by: Jialin LV, et al.
Published: (2016-08-01) -
A Rare Case of Primary Pulmonary Anaplastic Large Cell Lymphoma
by: Joana Carvalho, et al.
Published: (2019-09-01)